STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer

Published:2021-09 Issue: Volume:Volume 14 Page:5505-5516
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Sun Jiale^ORCID,Wei Xuedong,You Jiawei,Yue Wenchang,Ouyang Jun,Ling Zhixin,Hou Jianquan

Publisher

Informa UK Limited

Subject

General Medicine

Reference42 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer

3. Kufukihara R, Kikuchi E, Ogihara K, et al. Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer. Ann Surg Oncol. 2021;28(9):5349–5359. doi:10.1245/s10434-021-09750-0

4. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

5. New Therapeutic Challenges in Advanced Bladder Cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and assessment of an angiogenesis-related gene signature for prognosis of head and neck squamous cell carcinoma;Discover Oncology;2024-07-16

2. From mechanism to therapy: the journey of CD24 in cancer;Frontiers in Immunology;2024-05-31

3. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer;European Journal of Medical Research;2024-02-09

4. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer;2024-01-03

5. Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancer;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3